Literature DB >> 25477508

Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Woo-Joo Song1, Eun-Ah Christine Song1, Min-Su Jung2, Sun-Hee Choi2, Hyung-Hwan Baik3, Byung Kwan Jin3, Jeong Hee Kim4, Sul-Hee Chung5.   

Abstract

Glycogen synthase kinase 3β (GSK3β) participates in many cellular processes, and its dysregulation has been implicated in a wide range of diseases such as obesity, type 2 diabetes, cancer, and Alzheimer disease. Inactivation of GSK3β by phosphorylation at specific residues is a primary mechanism by which this constitutively active kinase is controlled. However, the regulatory mechanism of GSK3β is not fully understood. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) has multiple biological functions that occur as the result of phosphorylation of diverse proteins that are involved in metabolism, synaptic function, and neurodegeneration. Here we show that GSK3β directly interacts with and is phosphorylated by Dyrk1A. Dyrk1A-mediated phosphorylation at the Thr(356) residue inhibits GSK3β activity. Dyrk1A transgenic (TG) mice are lean and resistant to diet-induced obesity because of reduced fat mass, which shows an inverse correlation with the effect of GSK3β on obesity. This result suggests a potential in vivo association between GSK3β and Dyrk1A regarding the mechanism underlying obesity. The level of Thr(P)(356)-GSK3β was higher in the white adipose tissue of Dyrk1A TG mice compared with control mice. GSK3β activity was differentially regulated by phosphorylation at different sites in adipose tissue depending on the type of diet the mice were fed. Furthermore, overexpression of Dyrk1A suppressed the expression of adipogenic proteins, including peroxisome proliferator-activated receptor γ, in 3T3-L1 cells and in young Dyrk1A TG mice fed a chow diet. Taken together, these results reveal a novel regulatory mechanism for GSK3β activity and indicate that overexpression of Dyrk1A may contribute to the obesity-resistant phenotype through phosphorylation and inactivation of GSK3β.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Dyrk1A; Enzyme Inactivation; Glycogen Synthase Kinase 3 (GSK-3); Obesity; Phosphorylation; Serine/Threonine Protein Kinase

Mesh:

Substances:

Year:  2014        PMID: 25477508      PMCID: PMC4303684          DOI: 10.1074/jbc.M114.594952

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Inhibition of adipogenesis by Wnt signaling.

Authors:  S E Ross; N Hemati; K A Longo; C N Bennett; P C Lucas; R L Erickson; O A MacDougald
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

2.  Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

Authors:  R Dajani; E Fraser; S M Roe; N Young; V Good; T C Dale; L H Pearl
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

3.  The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

Authors:  Y L Woods; P Cohen; W Becker; R Jakes; M Goedert; X Wang; C G Proud
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 4.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

5.  Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α.

Authors:  Jung-Hwa Park; Min-Su Jung; Yeun-Soo Kim; Woo-Joo Song; Sul-Hee Chung
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

6.  Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3.

Authors:  Sooho Lee; Woo Kyeom Yang; Ji Ho Song; Young Min Ra; Jin-Hyun Jeong; Wonchae Choe; Insug Kang; Sung-Soo Kim; Joohun Ha
Journal:  Biochem Pharmacol       Date:  2013-01-18       Impact factor: 5.858

7.  Regulation of Wnt signaling during adipogenesis.

Authors:  Christina N Bennett; Sarah E Ross; Kenneth A Longo; Laszlo Bajnok; Nahid Hemati; Kirk W Johnson; Stephen D Harrison; Ormond A MacDougald
Journal:  J Biol Chem       Date:  2002-06-07       Impact factor: 5.157

8.  Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass.

Authors:  Latif Rachdi; Dulanjalee Kariyawasam; Fanny Guez; Virginie Aïello; Maria L Arbonés; Nathalie Janel; Jean-Maurice Delabar; Michel Polak; Raphaël Scharfmann
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

9.  Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Authors:  Vassiliki Fotaki; Mara Dierssen; Soledad Alcántara; Salvador Martínez; Eulàlia Martí; Caty Casas; Joana Visa; Eduardo Soriano; Xavier Estivill; Maria L Arbonés
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals.

Authors:  Seung-Hyun Hong; Kyu-Sun Lee; Su-Jin Kwak; Ae-Kyeong Kim; Hua Bai; Min-Su Jung; O-Yu Kwon; Woo-Joo Song; Marc Tatar; Kweon Yu
Journal:  PLoS Genet       Date:  2012-08-02       Impact factor: 5.917

View more
  26 in total

1.  LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice.

Authors:  Alizée Latour; Yuchen Gu; Nadim Kassis; Fabrice Daubigney; Catherine Colin; Blandine Gausserès; Sandrine Middendorp; Jean-Louis Paul; Valérie Hindié; Jean-Christophe Rain; Jean-Maurice Delabar; Eugene Yu; Mariona Arbones; Michel Mallat; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2018-05-30       Impact factor: 5.590

2.  DYRK1B regulates Hedgehog-induced microtubule acetylation.

Authors:  Rajeev Singh; Philipp Simon Holz; Katrin Roth; Anna Hupfer; Wolfgang Meissner; Rolf Müller; Malte Buchholz; Thomas M Gress; Hans-Peter Elsässer; Ralf Jacob; Matthias Lauth
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

3.  CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition.

Authors:  Yassan Abdolazimi; Zhengshan Zhao; Sooyeon Lee; Haixia Xu; Paul Allegretti; Timothy M Horton; Benjamin Yeh; Hannah P Moeller; Robert J Nichols; David McCutcheon; Aryaman Shalizi; Mark Smith; Neali A Armstrong; Justin P Annes
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

4.  DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome.

Authors:  Jianxing Xiang; Su Yang; Ning Xin; Marta A Gaertig; Roger H Reeves; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

5.  Genetic analysis of very obese children with autism spectrum disorder.

Authors:  Herman D Cortes; Rachel Wevrick
Journal:  Mol Genet Genomics       Date:  2018-01-11       Impact factor: 3.291

6.  SIRT2 deacetylase regulates the activity of GSK3 isoforms independent of inhibitory phosphorylation.

Authors:  Mohsen Sarikhani; Sneha Mishra; Sangeeta Maity; Chaithanya Kotyada; Donald Wolfgeher; Mahesh P Gupta; Mahavir Singh; Nagalingam R Sundaresan
Journal:  Elife       Date:  2018-03-05       Impact factor: 8.140

7.  A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform.

Authors:  Zhengshan Zhao; Yassan Abdolazimi; Neali A Armstrong; Justin P Annes
Journal:  J Vis Exp       Date:  2016-07-16       Impact factor: 1.355

8.  Anti-malarial Activities of Two Soil Actinomycete Isolates from Sabah via Inhibition of Glycogen Synthase Kinase 3β.

Authors:  Dhiana Efani Dahari; Raifana Mohamad Salleh; Fauze Mahmud; Lee Ping Chin; Noor Embi; Hasidah Mohd Sidek
Journal:  Trop Life Sci Res       Date:  2016-08

9.  Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.

Authors:  Jenna A Levy; Christy W LaFlamme; George Tsaprailis; Gogce Crynen; Damon T Page
Journal:  Biol Psychiatry       Date:  2021-04-08       Impact factor: 12.810

10.  In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome.

Authors:  Gaëlle Naert; Valentine Ferré; Emeline Keller; Amy Slender; Dorota Gibbins; Elizabeth Mc Fisher; Victor Lj Tybulewicz; Tangui Maurice
Journal:  J Psychopharmacol       Date:  2017-12-07       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.